FDA Inspection
Peter J. Winkle M.D.Peter J. Winkle M.D. – FDA Inspection, May 22, 2013
Record Details
This FDA Inspection record concerns Peter J. Winkle M.D., with an inspection on May 22, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Peter J. Winkle M.D.
- Inspection Date
- May 22, 2013
- Product Type
- Drugs
View Company Profile
ID · d7758642-60b5-404c-84c5-819182c09e5d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 832561
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Peter J. Winkle M.D.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| October 4, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 20, 2020 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| November 25, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 22, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Peter J. Winkle M.D.
- FDA Inspection 1251470 - 2024-10-04
- FDA Inspection 1133676 - 2020-11-20
- FDA Inspection 1111920 - 2019-11-25
- FDA Inspection 1100776 - 2019-08-22
- FDA Inspection 1048939 - 2018-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.